During the past decade, Clinical Research Hospital Tokyo conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Hospital Tokyo" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 2 trials sponsored, "Janssen Pharmaceutical K.K." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Mitsubishi Tanabe Pharma Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Hospital Tokyo" #1 collaborator was "Takeda" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Hospital Tokyo" are "Alzheimer Disease" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Healthy" (2 trials), "Cognitive Dysfunction" (1 trials) and "Dementia" (1 trials). Many other conditions were trialed in "Clinical Research Hospital Tokyo" in a lesser frequency.

Most popular intervention types in "Clinical Research Hospital Tokyo" are "Drug" (12 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Ad26/protein preF RSV Vaccine" (1 trials), "Bococizumab (PF-04950615;RN316)" (1 trials), "Donanemab" (1 trials) and "Ezetimibe" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Hospital Tokyo" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Research Hospital Tokyo". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Clinical Research Hospital Tokyo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Hospital Tokyo, 9 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".